Table 2.
CRP (mg/L) parametrization | Cohort 1 (Original) |
Cohort 2 (Validation) |
||||
---|---|---|---|---|---|---|
N below cut-off (%) | Harrell’s C statistic | AIC | N below cut off (%) | Harrell’s C statistic | AIC | |
Null (CRP not included) | NA | 0.6592 | 5224.41 | NA | 0.6816 | 428.58 |
CRP ≥ 10 | 132 (8.6%) | 0.6697 | 5174.10 | 39 (15.2%) | 0.6811 | 430.58 |
CRP ≥ 15 | 190 (12.4%) | 0.6797 | 5159.14 | 56 (21.8%) | 0.6995 | 429.22 |
CRP ≥ 20 | 230 (15.0%) | 0.6858 | 5148.08 | 66 (25.7%) | 0.7024 | 426.59 |
CRP ≥ 25 | 279 (18.2%) | 0.6930 | 5144.01 | 75 (29.2%) | 0.7055 | 427.83 |
CRP ≥ 30 | 326 (21.3%) | 0.6953 | 5143.46 | 83 (32.3%) | 0.7044 | 427.44 |
CRP ≥ 35 | 381 (24.9%) | 0.6963 | 5141.06 | 91 (35.4%) | 0.7145 | 425.61 |
CRP ≥ 40 | 439 (28.7%) | 0.7024 | 5136.10 | 96 (37.4%) | 0.7187 | 424.35 |
CRP ≥ 45 | 486 (31.7%) | 0.7055 | 5132.53 | 103 (40.1%) | 0.7015 | 427.18 |
CRP ≥ 50 | 530 (34.6%) | 0.7059 | 5126.61 | 111 (43.2%) | 0.6974 | 428.68 |
CRP ≥ 55 | 569 (37.1%) | 0.7025 | 5130.50 | 120 (46.7%) | 0.6900 | 428.85 |
CRP ≥ 60 | 605 (39.5%) | 0.7064 | 5127.69 | 125 (48.6%) | 0.6926 | 428.16 |
CRP ≥ 65 | 648 (42.3%) | 0.7068 | 5124.45 | 129 (50.2%) | 0.6867 | 428.47 |
CRP ≥ 70 | 687 (44.8%) | 0.7033 | 5131.22 | 135 (52.5%) | 0.6895 | 428.32 |
CRP ≥ 75 | 727 (47.5%) | 0.7006 | 5131.79 | 139 (54.1%) | 0.6879 | 428.87 |
CRP ≥ 80 | 766 (50.0%) | 0.7005 | 5133.82 | 145 (56.4%) | 0.6853 | 429.49 |
CRP ≥ 85 | 804 (52.5%) | 0.7021 | 5135.11 | 155 (60.3%) | 0.6887 | 429.16 |
CRP ≥ 90 | 834 (54.4%) | 0.7001 | 5138.43 | 161 (62.6%) | 0.6816 | 430.34 |
CRP ≥ 95 | 863 (56.3%) | 0.6975 | 5142.08 | 169 (65.8%) | 0.6828 | 429.98 |
CRP ≥ 100 | 887 (57.9%) | 0.7010 | 5137.48 | 173 (67.3%) | 0.6890 | 429.69 |
CRP (linear) | NA | 0.7040 | 5024.81 | NA | 0.6992 | 426.42 |
log(CRP) | NA | 0.7157 | 5001.00 | NA | 0.7014 | 426.51 |
Number of cases defined as not elevated CRP.
NA, not available.